Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,899.60
(
0.11%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.14
(
-0.92%
)
Bitcoin
77,521.05
(
1.56%
)
News Focus
News Focus
Post# of 822356
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Nemesis18

Send PM Follow Ignore
Followers 6
Posts 1903
Boards Moderated 0
Alias Born 03/04/2024

Nemesis18

Re: seekinganswers post# 796387

Wednesday, 11/05/2025 3:13:09 PM

Wednesday, November 05, 2025 3:13:09 PM

Post# of 822356
The Regulator, is fully aware of the very sketchy track history of this scam biotech company, and there is no way that they will ever be allowed to fleece both the NHS &/ or its most vulnerable patients.
Like wise, the NICE will be simply unable to cost this 'treatment', especially given how its 'success' rate was derived at, using 'pic n mix' data.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News